SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001104659-22-099810
Filing Date
2022-09-14
Accepted
2022-09-14 06:01:08
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A adxn-20220630x6k.htm 6-K/A 16939
2 EXHIBIT 99.1 adxn-20220630xex99d1.htm   iXBRL EX-99.1 1604749
  Complete submission text file 0001104659-22-099810.txt   7064485

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adxn-20220630.xsd EX-101.SCH 67079
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adxn-20220630_cal.xml EX-101.CAL 60943
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adxn-20220630_def.xml EX-101.DEF 159167
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxn-20220630_lab.xml EX-101.LAB 425989
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxn-20220630_pre.xml EX-101.PRE 303389
72 EXTRACTED XBRL INSTANCE DOCUMENT adxn-20220630xex99d1_htm.xml XML 1516974
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39179 | Film No.: 221242014
SIC: 2834 Pharmaceutical Preparations